Company Info
Phone(858) 434-1113
Year Established
1997
Ticker
ONCT
Exchange
NASDAQ
Contacts
James Breitmeyer, MD, PhDPresident & CEO
Chase Leavitt
General Counsel
Pablo Urbaneja
Senior VP, Corporate Development
Richard Vincent
CFO
Salim Yazji, M.D.
CMO
Rajesh Krishnan, PhD
CTO
David F. Hale
Chair
Company Description
Oncternal Therapeutics, formerly GTx, is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need.
